Eva Tiensuu Janson

Predictive and prognostic factors for treatment and survival in 305 patients with advanced gastrointestinal neuroendocrine carcinoma (WHO G3): The NORDIC NEC study

Staffan Welin, Seppo W. Langer, Lene Weber Vestermark et al. · Annals of Oncology · 2012 · 1K citations

Medicine, Oncology, Surgery +12

Temozolomide as Monotherapy Is Effective in Treatment of Advanced Malignant Neuroendocrine Tumors

Sara Ekeblad, Anders Sundin, Eva Tiensuu Janson et al. · Clinical Cancer Research · 2007 · 476 citations · Full text

Medicine, Oncology, Pharmacology +13

Mosaic loss of chromosome Y in peripheral blood is associated with shorter survival and higher risk of cancer

Lars A. Forsberg, Chiara Rasi, Niklas Malmqvist et al. · Nature Genetics · 2014 · 459 citations · Full text

Life Sciences, Genetics, Oncology +14

Carcinoid tumors: Analysis of prognostic factors and survival in 301 patients from a referral center

Eva Tiensuu Janson, Lars Holmberg, Mats Stridsberg et al. · Annals of Oncology · 1997 · 458 citations

Medicine, Oncology, Surgery +14

ENETS Consensus Guidelines for the Standards of Care in Neuroendocrine Neoplasms: Peptide Receptor Radionuclide Therapy with Radiolabelled Somatostatin Analogues

Rodney J. Hicks, Dik J. Kwekkeboom, Eric P. Krenning et al. · Neuroendocrinology · 2017 · 331 citations

Medicine, Nuclear Medicine, Oncology +17